These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 30595293)
1. Cardiac resynchronization therapy is associated with improvement in clinical outcomes in Indian heart failure patients: Results of a large, long-term observational study. Naik A; Singh B; Yadav R; Pandurangi U; Kler TS; Shankar B; Radhakrishnan R; Rajan V; Bhatia V; Kaul U; Varma J; Dora S; Narasimhan C Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S377-S383. PubMed ID: 30595293 [TBL] [Abstract][Full Text] [Related]
2. Adherence to 2016 European Society of Cardiology guidelines predicts outcome in a large real-world population of heart failure patients requiring cardiac resynchronization therapy. Stabile G; Pepi P; Palmisano P; D'Onofrio A; De Simone A; Caico SI; Pecora D; Rapacciuolo A; Arena G; Marini M; Pieragnoli P; Badolati S; Savarese G; Maglia G; Iuliano A; Botto GL; Malacrida M; Bertaglia E Heart Rhythm; 2018 Nov; 15(11):1675-1682. PubMed ID: 29665405 [TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF. Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311 [TBL] [Abstract][Full Text] [Related]
4. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study. Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764 [TBL] [Abstract][Full Text] [Related]
5. Effect of Diabetes Mellitus on Cardiac Resynchronization Therapy and to Prognosis in Heart Failure (from the Prospective Evaluation of Asian With Cardiac Resynchronization Therapy for Heart Failure Study). Tan ESJ; Lim J; Chan SP; Seow JT; Singh D; Yeo WT; Lim TW; Kojodjojo P; Seow SC Am J Cardiol; 2019 Sep; 124(6):899-906. PubMed ID: 31326077 [TBL] [Abstract][Full Text] [Related]
6. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT). Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576 [TBL] [Abstract][Full Text] [Related]
7. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure. Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR; Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828 [TBL] [Abstract][Full Text] [Related]
8. The effectiveness of CRT on improvement of survival of heart failure patients in real life clinical settings. Hudak M; Kerekanic M; Misikova S; Komanova E; Boho A; Stancak B Acta Cardiol; 2017 Apr; 72(2):180-187. PubMed ID: 28597793 [TBL] [Abstract][Full Text] [Related]
9. Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes. Goldstein SA; Mentz RJ; Hellkamp AS; Randolph TC; Fonarow GC; Hernandez A; Yancy CW; Al-Khatib SM Clin Cardiol; 2019 Feb; 42(2):256-263. PubMed ID: 30548280 [TBL] [Abstract][Full Text] [Related]